Villejuif, France, May 30, 2023 at 6:00 p.m. CET – PREDILIFE
(Euronext Growth: ALPRE FR0010169920), a specialist in artificial intelligence methods for predicting the risks of pathologies for personalized medicine, conducted a study on the prevention of the health of employees in companies, in collaboration with the polling institute IPSOS. 1,000 employees of private or semi-public companies responded to a self-administered online questionnaire from March 24 to 29 and 181 decision-makers working in private companies with at least 100 employees responded to the telephone survey of March 27 to April 27, 2023.
The three main lessons of this study:
-
Employees and decision-makers establish a direct link between the well-being and health of employees and business performance
: employees indeed attribute an average score of 7.6/10 and 7.5/10 on the decision-makers’ side. While 24% of the companies questioned have a dedicated health budget, 95% of employees consider that this budget is necessary within the framework of the actions carried out by the company.
-
8 out of 10 employees are sensitive to the consideration of the health of employees by the company when choosing the company in which they wish to work.
-
The introduction of predictive medicine into companies is very well received by employees:
in fact, 68% of employees say they are interested in carrying out a predictive balance sheet in the event that their company offers them this system.
”
The results of this study are very promising for the future. The post-Covid context and the current need to improve the employer brand confirm the company’s fundamental role in preventing employee health. Our offer of predictive assessments relating to the main cancers and cardiovascular diseases appears as an opportunity to increase the link between the company and its human resources, which is beneficial both for the performance of the company and from the point of view of the ESG criteria”
says Stéphane Ragusa, Chairman and CEO of PREDILIFE.
About PREDILIFE
PREDILIFE is a pioneer in the design and development of predictive tests intended to prevent the main diseases. It uses artificial intelligence methods applied to clinical and genetic medical data in a secure legal framework. The prediction of these individual risks makes it possible to propose a personalized monitoring protocol and earlier identification of pathologies.
For more information: www.predilife.com
|
contacts PREDILIFE Investor Relations Stephane Ragusa Chairman and CEO CAPVALUE Press Relations |
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
yJ1qY5ZrlmrGl5pxaJ2ZbmqVmplqlJPGZpeZlWKel5bJa25jmmxkaZbIZnFhlmtt
– To check this key:
https://www.security-master-key.com.
Regulated information:
Inside information:
– Other press releases
Full and original press release in PDF format:
https://www.actusnews.com/news/80167-cp-ipsos-def.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com